APS.TO
Price:
$0.57
Market Cap:
$7.61M
Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology primarily in the United States. Its clinical programs include APTO-253, which is in Phase 1a/b clinical trial for the treatment of patients with relapsed or refractory blood cancers, including acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (HR MDS); and HM43239 that is in Phase 1/2 clinical trial to treat patients with relapsed or refractory AML. The company also develops luxeptinib, which is in Phase 1a/b clinical trial for treating patients with relapsed or refractory B-cell malignancies, including chronic lymphocytic...[Read more]
Industry
Biotechnology
IPO Date
1996-04-25
Stock Exchange
TSX
Ticker
APS.TO
According to Aptose Biosciences Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 0.80. This represents a change of -22.80% compared to the average of 1.04 of the last 4 quarters.
The mean historical Current Ratio of Aptose Biosciences Inc. over the last ten years is 9.23. The current 0.80 Current Ratio has changed 765.59% with respect to the historical average. Over the past ten years (40 quarters), APS.TO's Current Ratio was at its highest in in the September 2020 quarter at 24.60. The Current Ratio was at its lowest in in the December 2023 quarter at 0.78.
Average
9.23
Median
7.77
Minimum
0.78
Maximum
18.36
Discovering the peaks and valleys of Aptose Biosciences Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 201.65%
Maximum Annual Current Ratio = 18.36
Minimum Annual Increase = -80.68%
Minimum Annual Current Ratio = 0.78
Year | Current Ratio | Change |
---|---|---|
2023 | 0.78 | -80.68% |
2022 | 4.03 | -59.69% |
2021 | 10.00 | -45.54% |
2020 | 18.36 | 2.97% |
2019 | 17.83 | 201.65% |
2018 | 5.91 | -11.77% |
2017 | 6.70 | 4.71% |
2016 | 6.40 | -27.58% |
2015 | 8.83 | -34.50% |
2014 | 13.49 | -15.62% |
The current Current Ratio of Aptose Biosciences Inc. (APS.TO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
4.94
5-year avg
10.20
10-year avg
9.23
Aptose Biosciences Inc.’s Current Ratio is less than Medicenna Therapeutics Corp. (9.43), less than Oncolytics Biotech Inc. (4.99), less than IMV Inc. (2.93), less than BELLUS Health Inc. (33.42), less than Aeterna Zentaris Inc. (5.94),
Company | Current Ratio | Market cap |
---|---|---|
9.43 | $155.90M | |
4.99 | $100.08M | |
2.93 | $13.12M | |
33.42 | $2.47B | |
5.94 | $25.38M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Aptose Biosciences Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Aptose Biosciences Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Aptose Biosciences Inc.'s Current Ratio?
How is the Current Ratio calculated for Aptose Biosciences Inc. (APS.TO)?
What is the highest Current Ratio for Aptose Biosciences Inc. (APS.TO)?
What is the 3-year average Current Ratio for Aptose Biosciences Inc. (APS.TO)?
What is the 5-year average Current Ratio for Aptose Biosciences Inc. (APS.TO)?
How does the current Current Ratio for Aptose Biosciences Inc. (APS.TO) compare to its historical average?